Watson's Generic Revatio Receives FDA Approval

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Watson Pharmaceuticals(NYSE: WPI) today announced that its subsidiary Watson Laboratories, Inc. hasreceived approval from the U.S. Food and Drug Administration (FDA) on itsAbbreviated New Drug Application (ANDA) for Sildenafil Tablets, 20 mg, thegeneric equivalent to Pfizer's Revatio^®. Watson intends to begin shippingthe product in the near future. Revatio^® is indicated for the treatment ofpulmonary arterial hypertension in adults to improve exercise ability anddelay clinical worsening.For the 12 months ending September 30, 2012, Revatio^® tablets had total U.S.sales of approximately $339 million according to IMS Health data.

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!